SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-07-006735
Filing Date
2007-05-04
Accepted
2007-05-04 09:28:18
Documents
6
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y34395e10vq.htm 10-Q 310845
2 EX-10.1: NON-EXCLUSIVE LICENSE AND MATERIAL TRANSFER AGREEMENT y34395exv10w1.htm EX-10.1 168165
3 EX-12.1: STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO COMBINED FIXED CHARGE y34395exv12w1.htm EX-12.1 19230
4 EX-31.1: CERTIFICATION y34395exv31w1.htm EX-31.1 9195
5 EX-31.2: CERTIFICATION y34395exv31w2.htm EX-31.2 9733
6 EX-32: CERTIFICATION y34395exv32.htm EX-32 3780
  Complete submission text file 0000950123-07-006735.txt   522250
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 07817961
SIC: 2834 Pharmaceutical Preparations